OCUL R&D to Revenue
Ocular Therapeutix Inc · R&D to Revenue
OCUL R&D to Revenue
Latest reported380.33%period ending
OCUL FY R&D/Revenue (115400.00% → 380.33%)
Latest values, visible window
High-resolution chart · PNG
OCUL r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 380.3253% | |
| 200.2966% | |
| 104.4693% | |
| 103.8218% | |
| 115.0751% | |
| 164.8796% | |
| 972.1079% | |
| 1,855.0251% | |
| 1,605.8242% | |
| 1,434.2872% | |
| 1,520.6286% | |
| 2,445.5959% | |
| 0% | |
| 115,400% |